The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including ...
The CHMP’s recommendation will be reviewed by the European Commission (EC), which is expected to make its final decision soon. Pfizer and BioNTech have already initiated manufacturing of the ...
Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and ...
Merck & Co. will partner with Protillion Biosciences to discover multiple new therapy candidates, through a collaboration ...
The University also introduced a new 4+1 pathway for biomedical engineering undergraduates to earn a bachelor and master’s ...
Zacks.com on MSN
Can Alnylam's Broader Portfolio Ease Its Dependence on Amvuttra?
Alnylam Pharmaceuticals’ ALNY primary top-line driver is its newest drug, Amvuttra (vutrisiran), which is approved in the ...
Strategic emphasis has shifted away from Novavax-led commercialization toward enabling partners with global scale, exemplified by Sanofi’s worldwide rights to market the COVID vaccine and Pfizer’s ...
Fujifilm outlived the decline of traditional photography and has logged record profits after diversifying into a wide range ...
The 2024-2025 COVID-19 vaccine was associated with reduced risk for COVID-19-related major adverse cardiovascular events ...
Building upon a deep understanding of immune cell activation, researchers from Children's Hospital of Philadelphia (CHOP) developed a new artificial platform that can be used to induce T cell ...
The analysis included 14,019 cases of the Delta variant – 166 of whom were hospitalised – between April 12 and June 4.
The Department of Health ? Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, and Children's Hospital of Philadelphia (CHOP) announced the signing of a Memorandum of Understanding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results